Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7

Cytometry

Volumn 29, Issue 4, 1997, Pages 306-312

  Koester, Steven K ^a   Roth, Patricia ^a   Mikulka, Warren R ^a   Schlossman, Stuart F ^b   Zhang, Chonghui ^b   Bolton, Wade E ^a  

^a Department of Scientific Research   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; CD95; Jurkat cells; Mitochondrial membrane protein; Monoclonal antibody APO2.7

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; LIPOCORTIN 5; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY APO 2.7; PHOSPHATIDYLSERINE; TRYPAN BLUE; TUBULIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIGHT SCATTERING; MICROSCOPY; MITOCHONDRIAL MEMBRANE; MONITORING; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL;

ANNEXIN A5; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; DNA FRAGMENTATION; DNA, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; MEMBRANE PROTEINS; MITOCHONDRIA;

EID: 0031434775     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19971201)29:4<306::AID-CYTO7>3.0.CO;2-7     Document Type: Article

References (57)

1. Arenas MJ, Morris RG, Wyllie AH: Apoptosis: The role of the endonuclease. Am J Pathol 136:593-608, 1990.
2. Carbonari M, Cibati M, Fiorilli M: Measurement of apoptotic cells in peripheral blood. Cytometry 22:161-167, 1995.
3. Cohen GM, Sun X-M, Snowden RT, Dinsdale D, Skilleter DN: Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 286:331-334, 1992.
4. Cohen JJ: Apoptosis: The physiologic pathway of cell death. Hosp Pract 15:35-43, 1993.
5. Cohen JJ: Overview: Mechanisms of apoptosis. Immunol Today 14:126-130, 1993.
6. Collins RJ, Harmon BV, Gobe GC, Kerr JFR: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radia Biol 61:451-453, 1992.
7. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808, 1992.
8. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F: Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1-20, 1997.
9. Don MM, Ablett G, Bishop CJ, Bundesen PG, Donald KJ, Searle J, Kerr JF: Death of cells by apoptosis following attachment of specifically allergized lymphocytes in vitro. Aust J Exp Biol Med Sci 55:407-417, 1977.
10. Duke RC, Chervenak R, Cohen JJ: Endogenous endonuclease-induced DNA fragmentation: An early event in cell-mediated cytolysis. Proc Natl Acad Sci USA 80:6361-6365, 1983.
11. Ellis RE, Yuan Y, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698, 1991.
12. Ferlini C, Di Cesare S, Rainaldi G, Malorni W, Samoggia P, Biselli R, Fattorossi A: Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 24:106-115, 1996.
13. Fesus L, Davies PJ, Piacentini M: Apoptosis: Molecular mechanisms in programmed cell death. Eur J Cell Biol 56:170-177, 1991.
14. Friesen C, Herr I, Krammer PH, Debatin K-M: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574-577, 1996.
15. Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, Darzynkiewicz Z: DNA strand breaks occurring during apoptosis: Their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1:639-648, 1992.
16. Henkart PA, Grinstein S: Apoptosis: Mitochondria resurrected? J Exp Med 183:1293-1295, 1996.
17. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Shameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991.
18. Jacobson MD, Burne JF, Raff MC: Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899-1910, 1994.
19. Jacobson MD, Raff MC: Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814-816, 1995.
20. Kerr JFR: Shrinkage necrosis: A distinct mode of cell death. J Pathol 105:13-20, 1971.
21. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972.
22. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-1420, 1994.
23. Kroemer G, Martínez A-C: Pharmacological inhibition of programmed lymphocyte death. Immunol Today 15:235-242, 1994.
24. Kroemer G, Zamzami N, Susin SA: Mitochondrial control of apoptosis. Immunol Today 18:44-51, 1997.
25. Li X, Darzynkiewicz Z: Labeling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation. Cell Prolif 28:571-579, 1995.
26. Majno G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-16, 1995.
27. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G: Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184:1155-1160, 1996.
28. Matter A: Microcinematographic and electron microscopic analysis of target cell lysis induced by cytotoxic T lymphocytes. Immunology 36:179-190, 1979.
29. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1455, 1995.
30. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M: Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12:3679-3684, 1993.
31. O'Brien MC, Bolton WE: Comparison of cell viability probes compatible with fixation and permeabilization for combined surface and intracellular staining in flow cytometry. Cytometry 19:243-255, 1995.
32. O'Brien MC, Gupta RK, Lee SY, Bolton WE: Use of a multiparametric panel to target subpopulations in a heterogeneous solid tumor model for improved analytical accuracy. Cytometry 21:76-83, 1995.
33. O'Brien MC, Healy SFJr, Raney SR, Hurst JM, Avner B, Hanly A, Mies C, Freeman JW, Snow C, Koester SK, Bolton WE: Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors. Cytometry 28:81-89, 1997.
34. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponsting H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715, 1992.
35. Ormerod MG, O'Neil CFO, Robertson D, Harrap KR: Cisplatin induces apoptosis in human ovarian carcinoma cell line without a concomitant internucleosomal degradation of DNA. Exp Cell Res 211:231-237, 1994.
36. Ormerod MG, Paul F, Cheetham M, Sun XM: Discrimination of apoptotic thymocytes by forward light scatter. Cytometry 21:300-304, 1995.
37. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon M-L: Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 130:157-167, 1995.
38. Roth PA, Mikulka WR, Smith CU, Bolton WE, Zhang C, Schlossman S: A novel marker for the measurement of apoptotic cells. Cytometry [Suppl] 8:44, 1996.
39. Sanderson CJ: The mechanism of T cell mediated cytotoxicity II. Morphological studies of cell death by time-lapse microcinematography. Proc R Soc Lond Biol 192:241-255, 1976.
40. Schulze-Osthoff K, Walczak H, Droge W, Krammer PH: Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127:15-20, 1994.
41. Seth A, Zhang C, Letvin N, Schlossman SF: Detection of apoptotic cells from peripheral blood of HIV-infected individuals using a novel monoclonal antibody. AIDS 11:1059-1061, 1997.
42. Stanger BZ: Looking beneath the surface: The cell death pathway of Fas/Apo-1 (CD95). Mol Med 2:7-20, 1996.
43. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879, 1994.
44. + thymocytes by flow cytometry. J Immunol Methods 137:79-87, 1991.
45. Trauth BC, Klas C, Peters SMJ, Matzku S, Moller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305, 1989.
46. van Engeland M, Ramaekers FCS, Schutte B, Reutelingsperger CPM: A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24:131-139, 1996.
47. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184:39-51, 1995.
48. Wolfgang H, Dazin P, Israel MA: Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 25:173-181, 1996.
49. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556, 1980.
50. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980.
51. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756, 1989.
52. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotee B, Kroemer G: Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367-377, 1995.
53. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssière JL, Petit PX, Kroemer G: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 181:1661-1672, 1995.
54. Zamzami N, Susin SA, Marchetti M, Hirsch T, Castedo M, Kroemer G: Mitochondrial control of nuclear apoptosis. J Exp Med 183:1533-1544, 1996.
55. Zhang C, Ao Z, Seth A, Schlossman SF: A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol 157:3980-3987, 1996
56. 42-50) is activated in human Jurkat cells undergoing apoptosis. Cell Immunol 165:161-167, 1995.
57. Zhang L, Wang C, Radvanyi LG, Miller RG: Early detection of apoptosis in defined lymphocyte populations in vivo. J Immunol Methods 181:17-27, 1995.